As of 2025-07-10, the Net Margin of Kolon Life Science Inc (102940.KQ) is -57.7%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -57.7% |
2023-12-31 | -24.7% |
2022-12-31 | 1.1% |
2021-12-31 | -0.8% |
2020-12-31 | -33.4% |
2019-12-31 | -62.2% |
2018-12-31 | -38.2% |
2017-12-31 | -1.2% |
2016-12-31 | 8% |
2015-12-31 | 0.7% |